UNLIMITED TURBO LONG - BAYER | Market Closed - Börse Stuttgart 10:34:56 2024-04-26 EDT | ||
| 0.33 EUR | +32.00% |
|
| Current month | -19.51% | ||
| 1 month | +10.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 0.33 | +10.00% | 0 |
| 24-04-25 | 0.3 | +20.00% | 0 |
| 24-04-24 | 0.25 | -13.79% | 0 |
| 24-04-23 | 0.29 | -3.33% | 0 |
| 24-04-22 | 0.3 | +57.89% | 0 |
Delayed Quote Börse Stuttgart
Last update April 26, 2024 at 10:34 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | 
BNP Paribas
|
| WKN | BN8P24 |
| ISIN | DE000BN8P244 |
| Date issued | 2011-03-18 |
| Strike | 24.71 € |
| Maturity | Unlimited |
| Parity | 9.84 : 1 |
| Emission price | 1.66 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.19 € |
|---|---|
| Lowest since issue | 0.14 € |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
27.4
EUR
Average target price
36.9
EUR
Spread / Average Target
+34.69%
- Stock Market
- Certificates
- Certificat
